Akanda Corp. Common Shares (AKAN)

Price$16.97

Value ScoreC

Growth ScoreF

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-9.49%

Price vs S&P 500 (4W)-66.45%

VGM Score33.85

Market Capitalization$11.75M

All Metrics

Book Value / Share (Quarterly)$101.98

P/TBV (Annual)0.42x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)172.38%

Cash Flow / Share (Quarterly)$-77.80

Price vs S&P 500 (YTD)102.56%

Gross Margin (TTM)29.10%

Net Profit Margin (TTM)-516.03%

EPS (TTM)$-294.14

10-Day Avg Trading Volume0.90M

EPS Excl Extra (TTM)$-294.14

EPS (Annual)$-276.39

ROI (Annual)-88.48%

Gross Margin (Annual)24.91%

Cash / Share (Quarterly)$77.96

Revenue Growth QoQ (YoY)-61.27%

ROA (Last FY)-51.76%

Revenue Growth TTM (YoY)-63.07%

EBITD / Share (TTM)$-78.24

Operating Margin (TTM)-512.69%

Cash Flow / Share (Annual)$-417.48

P/B Ratio3.56x

P/B Ratio (Quarterly)0.31x

Net Income / Employee (Annual)$-819,200

EV / Revenue (TTM)7.27x

Net Interest Coverage (TTM)-13.42x

ROA (TTM)-75.83%

EPS Incl Extra (Annual)$-276.39

Current Ratio (Annual)1.39x

Quick Ratio (Quarterly)1.24x

3-Month Avg Trading Volume1.64M

52-Week Price Return-74.55%

Revenue / Employee (TTM)$262,700

Tangible BV / Share (Quarterly)$101.98

P/S Ratio (Annual)14.05x

Asset Turnover (Annual)0.11x

52-Week High$209.03

EPS Excl Extra (Annual)$-276.39

26-Week Price Return6.44%

Quick Ratio (Annual)1.28x

13-Week Price Return431.16%

Total Debt / Equity (Annual)0.08x

Current Ratio (Quarterly)1.25x

Enterprise Value$9.55M

Asset Turnover (TTM)0.15x

Revenue / Employee (Annual)$167,300

Inventory Turnover (Annual)0.98x

Pretax Margin (Annual)-390.65%

Cash / Share (Annual)$263.64

3-Month Return Std Dev512.96%

Net Income / Employee (TTM)$-1,355,800

ROE (Last FY)-95.78%

Net Interest Coverage (Annual)-11.47x

EPS Basic Excl Extra (Annual)$-276.39

Receivables Turnover (TTM)4.01x

Total Debt / Equity (Quarterly)0.10x

EPS Incl Extra (TTM)$-294.14

Receivables Turnover (Annual)2.61x

ROI (TTM)-141.61%

P/S Ratio (TTM)8.95x

Revenue / Share (Annual)$56.45

Tangible BV / Share (Annual)$292.63

Price vs S&P 500 (52W)-102.75%

Year-to-Date Return113.50%

5-Day Price Return-18.92%

EPS Normalized (Annual)$-276.39

Net Profit Margin (Annual)-489.57%

Month-to-Date Return-55.09%

Cash Flow / Share (TTM)$-0.19

EBITD / Share (Annual)$-270.92

Operating Margin (Annual)-496.75%

LT Debt / Equity (Annual)0.00x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-294.14

P/TBV (Quarterly)0.31x

P/B Ratio (Annual)0.41x

Inventory Turnover (TTM)1.45x

Pretax Margin (TTM)-417.91%

Book Value / Share (Annual)$293.72

Price vs S&P 500 (13W)421.41%

Beta14.20x

Revenue / Share (TTM)$88.64

ROE (TTM)-153.25%

52-Week Low$2.29

vGradeC

gGradeF

mGradeC

vgmGradeD

Show chart for

Industry Peers — Pharmaceutical Preparations(17)

Symbol	Value Score	Growth Score	Momentum Score	Price
AKANAkanda Corp. Common Shares	C	F	C	$16.97
DFTXDefinium Therapeutics, Inc. Common Shares	—	—	A	$24.06
CRONCronos Group Inc. Common Share	C	B	B	$2.82
TLRYTilray Brands, Inc. Common Stock	B	B	D	$5.49
CGCCanopy Growth Corporation Common Shares	B	D	D	$1.08
USNAUSANA Health Sciences Inc	B	D	D	$18.33
NAGENiagen Bioscience, Inc. Common Stock	C	B	D	$3.61
SNDLSundial Growers Inc. Common Shares	A	C	C	$1.46
ACBAurora Cannabis Inc. Common Shares	B	D	D	$3.64
MDWDMediWound Ltd.	D	F	D	$13.82
FTLFFitLife Brands, Inc. Common Stock	B	C	D	$9.91

About

Akanda Corp is a vertically integrated cannabis company that cultivates, manufactures, and distributes medical cannabis products in the United Kingdom. The company generates substantially all of its revenue through its Distribution segment, which supplies medical cannabis oils and cannabis flower products. By controlling cultivation, manufacturing, and distribution, Akanda maintains an integrated supply chain for its medical cannabis business.